URTY is the ProShares UltraPro Russell2000, an exchange-traded fund designed to deliver three times (3x) the daily performance of the Russell 2000 Index, a market-cap-weighted benchmark of U.S. small-capitalization companies. The fund achieves its leverage primarily through total return swaps and futures contracts rather than by directly holding every underlying stock, and it is structured as a non-diversified fund. Its net expense ratio is 0.95%.
Because it resets leverage daily, URTY is a tactical trading and hedging tool rather than a buy-and-hold vehicle. Over holding periods longer than a single day, returns can diverge meaningfully from three times the index's cumulative return, especially during volatile or range-bound markets. This "volatility drag" is a structural characteristic investors must weigh in any future outlook.
The underlying index spans roughly 2,000 small-cap names, with sector exposure tilted toward Health Care (about 18%), Financials (about 17%), Industrials (about 17%), and Information Technology (about 15%), followed by Consumer Discretionary and Real Estate. This domestic-heavy, cyclical composition means the fund's future performance potential is tightly linked to U.S. economic growth, credit conditions, and the health of regional banks and small manufacturers rather than to the global mega-cap technology trade.
The broader macro backdrop remains the central variable in any URTY forecast. After a period in which markets oscillated between expectations of easing and the risk of renewed tightening, the direction of short-term interest rates now functions as a key swing factor. Lower policy rates and easing financial conditions would disproportionately benefit the indebted, domestically oriented companies that dominate the Russell 2000, while a higher-for-longer or hiking environment would act as a headwind.
Inflation remains sticky in some components, keeping the Federal Reserve's path uncertain. At the same time, U.S. economic growth has stabilized, supported by resilient consumer spending, fiscal initiatives, and significant capital expenditure — including artificial-intelligence infrastructure buildout. This capex cycle increasingly benefits second-order beneficiaries across technology, industrials, and connectivity providers, many of which reside in the small-cap universe.
The sector outlook is constructive where earnings breadth broadens. Small-cap financials could benefit from improved lending standards and steeper or more normalized yield conditions, while industrials and health care stand to gain from domestic investment and steady demand. A key risk remains the extreme concentration of large-cap equity returns; if leadership broadens, small caps are a natural beneficiary, but if the mega-cap trade reasserts itself, relative small-cap momentum could stall.
For traders seeking a data-driven edge in timing leveraged small-cap exposure, Tickeron's Trend Prediction Engine offers an AI-powered forecasting tool designed to help identify whether a stock, ETF, or other asset may trend bullish, bearish, or sideways over the coming week or month. The engine is built to help users spot developing trends, evaluate potential breakouts or reversals, and explore predictions across a broad range of tradable instruments. With searchable prediction categories, historical context, and alert-oriented functionality, it aims to support more informed decision-making. Explore the Trend Prediction Engine to see how its signals align with your market outlook.
Over a longer horizon, several structural themes could shape the small-cap universe underlying URTY. First, the historically wide valuation discount of small caps relative to large caps suggests that a range of well-known risks — slower growth, higher leverage, and weaker balance sheets — may already be reflected in prices. If earnings growth reaccelerates as expected, that discount leaves room for multiple expansion.
Second, policy dynamics matter disproportionately for smaller companies. Deregulation, domestic reshoring, infrastructure spending, and AI-adjacent capital expenditure all favor businesses with concentrated U.S. revenue exposure, a hallmark of the Russell 2000. Demographic and labor-market trends supporting domestic consumption could reinforce this tilt.
Third, interest-rate cycles remain pivotal. A normalization toward lower rates would ease the refinancing burden that has weighed on small-cap profitability, while a prolonged high-rate environment would keep pressure on margins. Finally, market-structure shifts — including elevated index concentration and a potential revival in M&A and IPO activity — could drive a durable broadening of market leadership away from a narrow group of mega-cap names.
Because URTY magnifies these underlying trends threefold on a daily basis, its long-term path depends not only on the direction of the Russell 2000 but also on the path volatility takes along the way. This makes the product a high-octane expression of a small-cap outlook rather than a passive core holding.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BSJT | 20.52 | -0.09 | -0.46% |
| Invesco BulletShares 2029 High Yield Corporate Bond ETF (BSJT) | |||
| DIVO | 43.98 | -0.68 | -1.52% |
| Amplify CWP Enhanced Dividend Income ETF (DIVO) | |||
| FID | 21.24 | -0.39 | -1.82% |
| First Trust S&P International Dividend Aristocrats ETF (FID) | |||
| WEEL | 18.15 | -0.61 | -3.25% |
| Peerless Option Income Wheel ETF (WEEL) | |||
| IBRN | 31.67 | -1.19 | -3.61% |
| iShares Neuroscience and Healthcare ETF (IBRN) | |||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IBRN | 31.67 | -1.19 | -3.61% |
| iShares Neuroscience and Healthcare ETF (IBRN) | |||
| WEEL | 18.15 | -0.61 | -3.25% |
| Peerless Option Income Wheel ETF (WEEL) | |||
| FID | 21.24 | -0.39 | -1.82% |
| First Trust S&P International Dividend Aristocrats ETF (FID) | |||
| DIVO | 43.98 | -0.68 | -1.52% |
| Amplify CWP Enhanced Dividend Income ETF (DIVO) | |||
| BSJT | 20.52 | -0.09 | -0.46% |
| Invesco BulletShares 2029 High Yield Corporate Bond ETF (BSJT) | |||
A.I.dvisor indicates that over the last year, URTY has been closely correlated with SSO. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if URTY jumps, then SSO could also see price increases.
| Ticker / NAME | Correlation To URTY | 1D Price Change % | ||
|---|---|---|---|---|
| URTY | 100% | -8.32% | ||
| SSO - URTY | 84% Closely correlated | -7.08% | ||
| SPXL - URTY | 84% Closely correlated | -10.51% | ||
| TQQQ - URTY | 77% Closely correlated | -15.94% | ||
| QLD - URTY | 76% Closely correlated | -10.86% | ||
| SOXL - URTY | 70% Closely correlated | -31.83% | ||
More | ||||
URTY saw its Momentum Indicator move below the 0 level on November 12, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned negative. In 86 of the 91 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for URTY turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 42 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.
The 50-day moving average for URTY moved below the 200-day moving average on November 04, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where URTY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for URTY entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for URTY's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +12.75% 3-day Advance, the price is estimated to grow further. Considering data from situations where URTY advanced for three days, in 282 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
URTY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.